Hanson Kristopher — SEC insider filings
SEC reporting owner CIK 1789970. 16 insider filings on record with FilingPulse; latest filed 2026-10-16.
Transaction summary — filings shown
Covers all 16 filings on record, filed 2020-11-23 to 2026-10-16. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 20 legs across 6 filings — 71,698 shares, $1,729,986 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 14.
- Largest priced transaction: sale of 9,030 shares @ $27.50 ($248,325) in MapLight Therapeutics, Inc., filed 2026-05-06.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| MapLight Therapeutics, Inc. (MPLT) | General Counsel | 10 | — | 20 legs · 71,698 sh · $1,729,986 | 7 |
| PhaseBio Pharmaceuticals Inc (PHAS) | SVP and General Counsel | 6 | — | — | 7 |
Insider filings — Hanson Kristopher
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-16 | 4 | MapLight Therapeutics, Inc. (MPLT) | Sale (S): 9,020 @ $8.08 | EDGAR |
| 2026-09-18 | 4 | MapLight Therapeutics, Inc. (MPLT) | Sale (S): 16,509 @ $11.67 | EDGAR |
| 2026-08-19 | 4 | MapLight Therapeutics, Inc. (MPLT) | Grant/award (A): 7,730 @ $0 · Grant/award (A): 31,395 (derivative) @ $0 | EDGAR |
| 2026-07-17 | 4 | MapLight Therapeutics, Inc. (MPLT) | Sale (S): 2,147 @ $36 · Sale (S): 5,103 @ $36.99 · Sale (S): 10 @ $37.54 · Sale (S): 4,776 @ $36.45 · Sale (S): 3,331 @ $37.26 · Sale (S): 11 @ $37.96 · +1 more | EDGAR |
| 2026-05-11 | 4 | MapLight Therapeutics, Inc. (MPLT) | Sale (S): 284 @ $27.61 · Sale (S): 846 @ $28.70 · Sale (S): 6,979 @ $30.04 · Sale (S): 5,808 @ $30.56 | EDGAR |
| 2026-05-06 | 4 | MapLight Therapeutics, Inc. (MPLT) | Sale (S): 9,030 @ $27.50 · Sale (S): 3,908 @ $28.29 · Sale (S): 296 @ $29.56 · Sale (S): 683 @ $30.08 | EDGAR |
| 2026-04-17 | 4 | MapLight Therapeutics, Inc. (MPLT) | Sale (S): 1,529 @ $26.80 · Sale (S): 73 @ $27.01 · Sale (S): 225 @ $27.49 | EDGAR |
| 2026-02-09 | 4 | MapLight Therapeutics, Inc. (MPLT) | Grant/award (A): 7,730 @ $0 · Grant/award (A): 31,395 (derivative) @ $0 | EDGAR |
| 2026-01-29 | 4 | MapLight Therapeutics, Inc. (MPLT) | Tax withholding (F): 26,007 @ $17.98 | EDGAR |
| 2025-10-28 | 4 | MapLight Therapeutics, Inc. (MPLT) | Grant/award (A): 27,098 @ $0 · Grant/award (A): 110,046 (derivative) @ $0 | EDGAR |
| 2022-05-24 | 4 | PhaseBio Pharmaceuticals Inc (PHAS) | Grant/award (A): 4,831 @ $0.68 | EDGAR |
| 2022-02-28 | 4 | PhaseBio Pharmaceuticals Inc (PHAS) | Grant/award (A): 18,750 (derivative) @ $0 · Grant/award (A): 87,500 (derivative) @ $0 | EDGAR |
| 2021-11-23 | 4 | PhaseBio Pharmaceuticals Inc (PHAS) | Grant/award (A): 1,545 @ $2.01 | EDGAR |
| 2021-05-24 | 4 | PhaseBio Pharmaceuticals Inc (PHAS) | Grant/award (A): 1,088 @ $2.80 | EDGAR |
| 2021-02-09 | 4 | PhaseBio Pharmaceuticals Inc (PHAS) | Grant/award (A): 36,000 (derivative) @ $0 | EDGAR |
| 2020-11-23 | 4 | PhaseBio Pharmaceuticals Inc (PHAS) | Grant/award (A): 999 @ $3 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2020-11-20 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1789970 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs